← Back to Conditions

Oligodendroglioma

disorder
SNOMED 443936004CUI C0028945

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Treatments & Interventions

Vorasidenib

substance

Clinical Trials

5
Total Trials
4
Recruiting
0
With Results

Recent Trials

All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma

NCT05345002Phase 2Recruiting55 enrolled

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

NCT03911388Phase 1Recruiting24 enrolled

Pediatric Long-Term Follow-up and Rollover Study

NCT03975829Phase 4Active Not Recruiting163 enrolled

Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas

NCT00268385Phase 1Active Not Recruiting83 enrolled

Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy

NCT06625047Phase 4Completed30 enrolled
View all 5 trials on ClinicalTrials.gov

Research Evidence

Peer-reviewed studies linked via MeSH term "Oligodendroglioma" from the MEDLINE/PubMed database.

Sort:
Adjuvant chemoradiotherapy with procarbazine, lomustine, and vincristine (PCV) or temozolomide for 1p/19q Co-deleted anaplastic oligodendroglioma: a systematic review and network meta-analysis.
[object Object], [object Object], [object Object] et al. · BMC Cancer · 2025
PMID: 41254593Meta-AnalysisFull text (PMC)
Genetically Distinct Oligosarcoma Arising from Oligodendroglioma: Systematic Review & Illustrative Case Example.
[object Object], [object Object], [object Object] et al. · World Neurosurg · 2024
PMID: 38490447Meta-Analysis
Frequency and Prognostic Impact of CDKN2A/B Alteration in Oligodendrogliomas: Systematic Review and Meta-analysis.
[object Object], [object Object], [object Object] · Neurol Med Chir (Tokyo) · 2024
PMID: 39443123Meta-AnalysisFull text (PMC)
A systematic review and meta-analysis informing the role of adjuvant radiotherapy (RT) in Grade 2 and 3 oligodendroglioma.
[object Object], [object Object], [object Object] et al. · J Clin Neurosci · 2024
PMID: 38981364Meta-Analysis
Artificial Intelligence Applications in Glioma With 1p/19q Co-Deletion: A Systematic Review.
[object Object], [object Object], [object Object] et al. · J Magn Reson Imaging · 2023
PMID: 37083159Meta-Analysis
Systematic Review of Molecular Targeted Therapies for Adult-Type Diffuse Glioma: An Analysis of Clinical and Laboratory Studies.
[object Object], [object Object], [object Object] et al. · Int J Mol Sci · 2023
PMID: 37445633Meta-AnalysisFull text (PMC)
Impact of extent of resection and adjuvant therapy in diffuse gliomas of the spine.
[object Object], [object Object], [object Object] et al. · Spine J · 2023
PMID: 36804437Meta-Analysis
Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta-analysis based on a Cochrane systematic review.
[object Object], [object Object], [object Object] et al. · Neuropathol Appl Neurobiol · 2022
PMID: 34958131Meta-AnalysisFull text (PMC)
Prevalence of seizures in brain tumor: A meta-analysis.
[object Object], [object Object], [object Object] et al. · Epilepsy Res · 2022
PMID: 36274423Meta-Analysis
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.
[object Object], [object Object], [object Object] et al. · Cochrane Database Syst Rev · 2022
PMID: 35233774Meta-AnalysisFull text (PMC)
Search all PubMed articles for Oligodendroglioma

Research data from MEDLINE/PubMed

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Astrocytoma
HP:0009592
Ependymoma
HP:0002888
Glioblastoma
HP:0012174

Related Conditions

Primary oligodendroglioma(child)
Oligodendroglioma of central nervous system(child)
Glioma(parent)
Malignant tumour(parent)

Quick Facts

SNOMED CT
443936004
UMLS CUI
C0028945
Fully Specified Name
Oligodendroglioma (disorder)
Specialists
0
Diagnostic Biomarkers
0
HPO Phenotypes
3
Known Treatments
1
Clinical Trials
5
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.